CompanyDrug

Terns Pharmaceuticals’ Oral GLP-1R Agonist TERN-601 Shows Promising Weight Loss Results in Phase I Trial

CompanyDrug

GSK’s Nucala Shows Promise in Phase III COPD Trial, MATINEE Results Positive

CompanyLegal / IP

US House Approves Biosecure Act with Implications for Chinese Biotech Firms

CompanyDrug

CIRC’s Subsidiary HTA Co., Ltd. Secures NMPA Approval for Sodium Fluoride [18F] for Bone Imaging

CompanyDrug

Fosun Pharmaceutical’s Daxxify Receives NMPA Approval for Aesthetic Use in China

CompanyDeals

Beijing Centergate Technologies and Bestcomm Pharmaceutical Form Strategic Partnership in Multiple Medical Fields

CompanyDrug

Jiangsu Hengrui’s ANGPTL3 Inhibitor SHR-1918 Earns Breakthrough Designation for HoFH Treatment

CompanyDeals

Chengdu Kanghua Biological Products Inks Five-Year Partnership to Boost Sichuan’s Biotech and Vaccine Industries

CompanyDeals

JHM Biopharma Secures Over USD 28 Million in Series B+ Financing to Boost Pipeline Development

CompanyMedical Device

Amoy Diagnostics’ AiHuiJie Lung Cancer Companion Diagnostic Receives NMPA Approval

CompanyDrug

AstraZeneca and Daiichi Sankyo’s Dato-DXd Misses Overall Survival Endpoint but Shows Promise in NSCLC Subgroup

CompanyDeals

Candel Therapeutics Acquires Bispecific Antibodies and Secures $370 Million in Financing for Autoimmune Drug Development